Lv1
20 积分 2023-10-10 加入
Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti‐interleukin‐6 receptor antibody
3天前
已完结
Natural polysaccharides as potential anti-fibrotic agents: A review of their progress
3天前
已完结
Inpatient Management of Epidermolysis Bullosa: Consensus-Based Hands-On Instructions for Neonates and Post-Neonates
13天前
已完结
Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa
26天前
已完结
TRPV3-Activated PARP1/AIFM1/MIF Axis through Oxidative Stress Contributes to Atopic Dermatitis
2个月前
已完结
Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations
2个月前
已完结
Olmsted Syndrome
2个月前
已完结
Olmsted Syndrome
3个月前
已完结
Genotype‐phenotype correlations on epidermolysis bullosa with congenital absence of skin: A comprehensive review
5个月前
已完结
868 Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa
5个月前
已完结
皖公网安备34019202002308
